scispace - formally typeset
S

Sha Song

Researcher at Chinese Academy of Sciences

Publications -  6
Citations -  90

Sha Song is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Prodrug & Internal medicine. The author has an hindex of 2, co-authored 5 publications receiving 40 citations. Previous affiliations of Sha Song include Nanchang University.

Papers
More filters
Journal ArticleDOI

Cholesterol-tuned liposomal membrane rigidity directs tumor penetration and anti-tumor effect.

TL;DR: The results showed that liposomes with moderate rigidity gained excellent tumor penetration and enhanced anti-tumor effects, and highlight the importance of liposomal membrane rigidity.
Journal ArticleDOI

Smart Tumor Microenvironment-Responsive Nanotheranostic Agent for Effective Cancer Therapy

TL;DR: In vivo pharmacodynamics results demonstrate that these synergetic effects caused by CaM‐PB NPs significantly contribute to the inhibition of tumor progression, demonstrating that theCaM‐ PB NPs with sequential theranostic functions are a promising system for effective cancer therapy.
Journal ArticleDOI

Silicone elastomer gel impregnated with 20( S )-protopanaxadiol-loaded nanostructured lipid carriers for ordered diabetic ulcer recovery

TL;DR: It is demonstrated that the developed PPD-NS could facilitate ordered diabetic wound recovery via multifunctional improvement during different wound-healing phases through suppressing inflammatory infiltration in the inflammatory phase, promoting angiogenesis during the proliferation phase, and regulating collagen deposition in the remodeling phase.
Journal ArticleDOI

Enzyme-Activated Prodrug-Based Smart Liposomes Specifically Enhance Tumor Hemoperfusion with Efficient Drug Delivery to Pancreatic Cancer Cells and Stellate Cells

TL;DR: By enhancing the exposure of DOX and CAL to tumor cells and aPSCs, respectively, in a tumor‐specific manner, MR‐T‐PD exerts superior efficacy without causing additional side effects, and represents a promising paradigm for pancreatic cancer therapy.
Journal ArticleDOI

Transfersomes improved delivery of ascorbic palmitate into the viable epidermis for enhanced treatment of melasma.

TL;DR: Ascorbic palmitate (AP) was encapsulated into the transfersomes (TFs), yielding AP-TFs, which utilized the deformability of TFs to squeeze through the skin pores in the stratum corneum under the transepidermal hydration gradient forces, leading to 14.1-fold increase in AP accumulation to the viable epidermis (EP).